🇺🇸 FDA
Patent

US 11696956

Bicyclic peptide ligands specific for EphA2

granted A61KA61K38/05A61K38/10

Quick answer

US patent 11696956 (Bicyclic peptide ligands specific for EphA2) held by BicycleTx Limited expires Mon Jul 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BicycleTx Limited
Grant date
Tue Jul 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/05, A61K38/10, A61K47/62, A61K47/64